Knightsbridge Asset Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Knightsbridge Asset Management's LLY Position: Q3 2026 in Review
Knightsbridge Asset Management reduced its Eli Lilly (LLY) stake by 0.28% in Q3 2026, selling an estimated $5.9K and leaving 1,804 shares worth $2.09M. The position accounts for 0.24% of the portfolio, ranked #66.
Knightsbridge Asset Management first reported a position in LLY in Q3 2022 and has held it in 17 quarters since. The position peaked at $2.17M in Q2 2026. 4,550 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- Knightsbridge Asset Management held 1,804 shares of Eli Lilly worth $2.09M as of Q3 2026.
- Knightsbridge Asset Management sold 5 Eli Lilly shares in Q3 2026, an estimated $5.9K.
- Eli Lilly made up 0.24% of Knightsbridge Asset Management's portfolio in Q3 2026, its #66 holding.
- Knightsbridge Asset Management first reported a position in Eli Lilly in Q3 2022 and has held it in 17 quarters since.
- Knightsbridge Asset Management's Eli Lilly position peaked at $2.17M in Q2 2026.
- 4,550 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on Knightsbridge Asset Management's 13F filing for Q3 2026, filed 13 Nov 2026.